Tuesday, September 15, 2026

Data Control Wars: Orchestra Group Unveils a Sovereign AI Cloud That Ditches Public Providers

Orchestra Group launches a Sovereign AI Cloud Data Center to enhance data sovereignty and control over AI infrastructure for organizations.

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical's symposium focused on menopausal hormone therapy, featuring discussions on Angeliq and recent clinical findings.

Revolutionizing Steel: How POSCO’s Smart Safety Operations Enhance Efficiency and Safety in 2026

POSCO's Pohang Steelworks launched a Smart Safety Operation Logic system, enhancing crane efficiency and safety through AI technology.

Tag: GLP-1 treatments

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price War in Korea’s Obesity Drug Market?

Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.